//

Media

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

August 12, 2022

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

C-Path’s Type 1 Diabetes Consortium (T1DC) is pleased to announce that “Consortium-based approach to receiving an EMA...

October 13, 2022-October 14, 2022

DIA 2022 Digital Technology in Clinical Trials Conference

Early bird rates in effect until August 18! C-Path’s eCOA Consortium is co-sponsoring the DIA 2022 Digital Technology in Clini

August 17, 2022

View Now | Addressing the Gaps in Clinical Trial Readiness for FSHD

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common myopathies affecting anywhere between 1:8,000 to 1:20,000

September 13, 2022-September 14, 2022

View Now | 2022 RDCA-DAP Workshop, September 13-14

Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i

PRO Consortium Announces Publication of Open Access Article

C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of chang

Diary for Irritable Bowel Syndrome Symptoms-Constipation Now Available for Licensing

C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) i

July 19, 2022

Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures

eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials

C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impair

C-Path’s Dr. Amanda Klein Promoted to Transplant Therapeutic Consortium Executive Director

TUCSON, Ariz., July 14, 2022 — Critical Path Institute (C-Path) has named Amanda Klein, Pharm.D., as Executive Director for its

Diamyd Medical Joins International Consortium in Type 1 Diabetes

TUCSON, Ariz., June 30, 2022 — Diamyd Medical will be a full voting member of the Type 1 Diabetes Consortium (T1DC) led by the U

Previous3031 32...114 Next